mRNA, SE-CAD and PCⅢ in AML patients, these three indicators are all independent risk factors affecting the prognosis of AML patients, and the combination of the three indicators can effectively predict the prognosis of the patients.
Keyphrases
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- prognostic factors
- acute myeloid leukemia
- peritoneal dialysis
- squamous cell carcinoma
- long non coding rna
- acute lymphoblastic leukemia
- patient reported outcomes
- allogeneic hematopoietic stem cell transplantation
- patient reported
- chemotherapy induced